Market Overview

UPDATE: Deutsche Bank Upgrades Perrigo Following Elan Acquisition Announcement

Share:
Related PRGO
Could M&A Boost Pfizer More? Jefferies Thinks So
Analysts Met With UnitedHealth And Mylan Management; What Happened?

In a report published Tuesday, Deutsche Bank analyst David M. Steinberg upgraded Perrigo (NYSE: PRGO) from Hold to Buy, and raised the price target from $120.00 to $150.00.

In the report, Deutsche Bank noted, “We believe the announced acquisition of Elan makes sense for a number of reasons (see below), and feel increasingly confident in the co's financial outlook for FY14. Post Monday's ~7% selloff, the $125 range (or 17x our pro forma CY14 EPS est) looks an attractive entry point – although technical factors and unease among some investors could create additional volatility near term. We now believe the shares are poised for outperformance over the next 12 months.”

Perrigo closed on Monday at $125.17.

Latest Ratings for PRGO

DateFirmActionFromTo
Apr 2015B RileyDowngradesBuyNeutral
Apr 2015UBSDowngradesBuyNeutral
Apr 2015Deutsche BankMaintainsBuy

View More Analyst Ratings for PRGO
View the Latest Analyst Ratings

Posted-In: David M. Steinberg Deutsche BankAnalyst Color Upgrades Analyst Ratings

 

Related Articles (PRGO)

Around the Web, We're Loving...